In patients with unresectable, locally advanced esophageal cancer, the triple combination of radiation, chemotherapy, and ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the ...

The company is paying China-based biotech LaNova Medicines $588 million for the same type of bispecific antibody drug that ...

Aggressive non-Hodgkin lymphoma is typically treated with intravenous chemo-immunotherapy. "This is a cocktail of various ...

"Some patients also receive chemotherapy, but the data are mixed on its effectiveness and it's also very toxic, so we were interested in seeing whether immunotherapy could improve outcomes for ...

Findings, demonstrated by the phase 2 PERLA trial, were presented at the 2024 Society for Immunotherapy of Cancer (SITC) ...

A new study out of Harvard Medical School is opening the door for cancer patients with a rare but dangerous heart condition ...

The insights from the study can be harnessed into further trials to benefit more nasopharyngeal cancer patients. Read more at ...

Researchers have developed a type of antibody that targets and delivers a drug package via the antibody itself, while ...

Cases of mouth cancer have reached a record high in England and Scotland, a new report shows. Last year, there were more than ...

The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell ...